A detailed history of Colonial Trust Advisors transactions in Organon & Co. stock. As of the latest transaction made, Colonial Trust Advisors holds 1,364 shares of OGN stock, worth $20,855. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,364
Previous 1,364 -0.0%
Holding current value
$20,855
Previous $28,000 7.14%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$17.45 - $21.96 $17 - $21
1 Added 0.07%
1,364 $28,000
Q4 2023

Feb 14, 2024

SELL
$10.95 - $17.32 $711 - $1,125
-65 Reduced 4.55%
1,363 $19,000
Q2 2023

Aug 14, 2023

SELL
$19.27 - $24.63 $366 - $467
-19 Reduced 1.31%
1,428 $29,000
Q1 2023

May 11, 2023

BUY
$21.42 - $32.08 $1,842 - $2,758
86 Added 6.32%
1,447 $34,000
Q4 2022

Feb 14, 2023

BUY
$23.31 - $28.61 $31,724 - $38,938
1,361 New
1,361 $38,000

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $3.89B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Colonial Trust Advisors Portfolio

Follow Colonial Trust Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Colonial Trust Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Colonial Trust Advisors with notifications on news.